81 FR 15110 - Proposed Substances To Be Evaluated for Set 30 Toxicological Profiles
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry Federal Register Volume 81, Issue 54 (March 21, 2016)
Agency for Toxic Substances and Disease Registry
Federal Register Volume 81, Issue 54 (March 21, 2016)
| Page Range | 15110-15111 | |
| FR Document | 2016-06277 |
[Federal Register Volume 81, Number 54 (Monday, March 21, 2016)] [Notices] [Pages 15110-15111] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-06277] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Toxic Substances and Disease Registry [Docket No. ATSDR-2016-0004] Proposed Substances To Be Evaluated for Set 30 Toxicological Profiles AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR), Department of Health and Human Services (HHS). ACTION: Request for comments on the proposed substances to be evaluated for Set 30 toxicological profiles. ----------------------------------------------------------------------- SUMMARY: ATSDR is initiating the development of its 30th set of toxicological profiles (CERCLA Set 30). This notice announces the list of proposed substances that will be evaluated for CERCLA Set 30 toxicological profile development. ATSDR's Division of Toxicology and Human Health Sciences is soliciting public nominations from the list of proposed substances to be evaluated for toxicological profile development. ATSDR also will consider the nomination of any additional, non-CERCLA substances that may have public health implications, on the basis of ATSDR's authority to prepare toxicological profiles for substances not found at sites on the National Priorities List. The agency will do so in order to ``. . . establish and maintain inventory [[Page 15111]] of literature, research, and studies on the health effects of toxic substances'' under CERCLA Section 104(i)(1)(B), to respond to requests for consultation under section 104(i)(4), and to support the site- specific response actions conducted by ATSDR, as otherwise necessary. DATES: Nominations from the Substance Priority List and/or additional substances must be submitted within 30 days of the publication of this notice. ADDRESSES: You may submit nominations, identified by Docket No. ATSDR- 2016-0004, by any of the following methods: *Internet: Access the Federal eRulemaking portal at http://www.regulations.gov. Follow the instructions for submitting comments. *Mail: Division of Toxicology and Human Health Sciences, 1600 Clifton Rd. NE., MS F-57, Atlanta, GA 30333 Instructions: All submissions must include the agency name and docket number for this notice. All relevant comments will be posted without change. This means that no confidential business information or other confidential information should be submitted in response to this notice. Refer to the section Submission of Nominations (below) for the specific information required. FOR FURTHER INFORMATION CONTACT: For further information, please contact Commander Jessilynn B. Taylor, Division of Toxicology and Human Health Sciences, 1600 Clifton Rd. NE., MS F-57, Atlanta, GA 30333, Email: [email protected]; phone: 770.488.3313. SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization Act of 1986 (SARA) [42 U.S.C. 9601 et seq.] amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain requirements for ATSDR and the U.S. Environmental Protection Agency (EPA) with regard to hazardous substances most commonly found at facilities on the CERCLA National Priorities List (NPL). Among these statutory requirements is a mandate for the Administrator of ATSDR to prepare toxicological profiles for each substance included on the Priority List of Hazardous Substances. This list identifies 275 hazardous substances that ATSDR and EPA have determined pose the most significant current potential threat to human health. Substances To Be Evaluated for Set 30 Toxicological Profiles Each year, ATSDR develops a list of substances to be considered for toxicological profile development. The Set 30 nomination process includes consideration of all substances on ATSDR's Priority List of Hazardous Substances, also known as the Substance Priority List (SPL), as well as other substances nominated by the public. The 275 substances on the SPL, as well as other substances nominated by the public, will be considered for Set 30 Toxicological Profile development. This list may be found at the following Web site: www.atsdr.cdc.gov/SPL. Submission of Nominations for the Evaluation of Set 30 Proposed Substances: Today's notice invites voluntary public nominations for substances included on the SPL and for substances not listed on the SPL. All nominations should include the full name of the nominator, affiliation, and email address. When nominating a non-SPL substance, please include the rationale for the nomination. Please note that email addresses will not be posted on regulations.gov. ATSDR will evaluate all data and information associated with nominated substances and will determine the final list of substances to be chosen for toxicological profile development. Substances will be chosen according to ATSDR's specific guidelines for selection. These guidelines can be found in the Selection Criteria announced in the Federal Register on May 7, 1993 (58FR27286-27287). A hard copy of the Selection Criteria is available upon request or may be accessed at: http://www.atsdr.cdc.gov/toxprofiles/guidance/criteria_for_selecting_tp_support.pdf. Please ensure that your comments are submitted within the specified nomination period. Nominations received after the closing date will be marked as late and may be considered only if time and resources permit. Dated: March 15, 2016. Pamela Protzel Berman, Acting Associate Director, Office of Policy, Planning and Evaluation, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry. [FR Doc. 2016-06277 Filed 3-18-16; 8:45 am] BILLING CODE 4163-70-P
![15110 Federal Register / Vol. 81, No. 54 / Monday, March 21, 2016 / Notices
3,000 finance companies has been must be received not later than April 5, at the Reserve Bank indicated or the
drawn for the FR 3033s. The survey will 2016. offices of the Board of Governors not
be sent on March 21, 2016, and will A. Federal Reserve Bank of Kansas later than April 5, 2016.
collect detailed information, as of City (Dennis Denney, Assistant Vice A. Federal Reserve Bank of
December 31, 2015, from both assets President) 1 Memorial Drive, Kansas Minneapolis (Jacquelyn K. Brunmeier,
and liability sides of the respondents’ City, Missouri 64198–0001: Assistant Vice President) 90 Hennepin
balance sheets, along with income and 1. Jerry G. Scott, as trustee of the Jerry Avenue, Minneapolis, Minnesota
expenses, the number of accounts and G. Scott Trust, both of Seminole, 55480–0291:
offices, and the small-business credit Oklahoma, and individually as a voting 1. Park Financial Group, Inc.,
they extend, if any. The data collected representative, John Barry Barringer, Minneapolis, Minnesota; to engage de
from this voluntary survey will be used Ardmore, Oklahoma; Lisa B. Boggs, novo in extending credit and servicing
for two purposes: to benchmark the Sulphur, Oklahoma; Hugh B. Warren, loans, pursuant to section 225.28(b)(1).
consumer and business finance series Jr., and Allene L. Warren, both of Ada, B. Federal Reserve Bank of Kansas
collected on the monthly Domestic Oklahoma, as members, of the Vision City (Dennis Denney, Assistant Vice
Finance Company Report of Bancshares, Inc. Shareholders’ President) 1 Memorial Drive, Kansas
Consolidated Assets and Liabilities (FR Agreement, Seminole, Oklahoma; to City, Missouri 64198–0001:
2248; OMB No. 7100–0005) and to retain voting shares of Vision 1. Washington 1st Banco, Inc.,
increase the Board’s understanding of Bancshares, Inc., and thereby indirectly Washington, Kansas; to continue to
an important part of the financial retain voting shares of Vision Bank, engage de novo in extending credit and
system. N.A., both in Ada, Oklahoma. servicing loans, pursuant to section
2. Twila V. Gregg, and Richard A. 225.28(b)(1).
Current Actions: On January 12, 2016,
Gregg, both of Lee’s Summit, Missouri;
the Federal Reserve published a notice Board of Governors of the Federal Reserve
to acquire voting shares of Urich
in the Federal Register (81 FR 1421) System, March 16, 2016.
Bancorp, Inc., and thereby indirectly
requesting public comment for 60 days Michael J. Lewandowski,
acquire voting shares of America’s
on the proposal to extend the FR 3033s Associate Secretary of the Board.
Community Bank, both in Blue Springs,
for three years and to revise the survey
Missouri. [FR Doc. 2016–06255 Filed 3–18–16; 8:45 am]
by adding a section to solicit
Board of Governors of the Federal Reserve BILLING CODE 6210–01–P
information from the finance companies
on income and expenses, number of System, March 16, 2016.
accounts and offices, and small business Michael J. Lewandowski,
credit they extend. The comment period Associate Secretary of the Board. DEPARTMENT OF HEALTH AND
for the notice expired on March 14, [FR Doc. 2016–06256 Filed 3–18–16; 8:45 am] HUMAN SERVICES
2016. The Federal Reserve did not BILLING CODE 6210–01–P
Agency for Toxic Substances and
receive any comments, and the Disease Registry
information collection will be revised as
proposed. FEDERAL RESERVE SYSTEM [Docket No. ATSDR–2016–0004]
Board of Governors of the Federal Reserve Notice of Proposals To Engage in or Proposed Substances To Be Evaluated
System, March 16, 2016. To Acquire Companies Engaged in for Set 30 Toxicological Profiles
Robert deV. Frierson, Permissible Nonbanking Activities
Secretary of the Board. AGENCY: Agency for Toxic Substances
[FR Doc. 2016–06278 Filed 3–18–16; 8:45 am] The companies listed in this notice and Disease Registry (ATSDR),
BILLING CODE 6210–01–P
have given notice under section 4 of the Department of Health and Human
Bank Holding Company Act (12 U.S.C. Services (HHS).
1843) (BHC Act) and Regulation Y, (12 ACTION: Request for comments on the
FEDERAL RESERVE SYSTEM CFR part 225) to engage de novo, or to proposed substances to be evaluated for
acquire or control voting securities or Set 30 toxicological profiles.
Change in Bank Control Notices; assets of a company, including the
Acquisitions of Shares of a Bank or companies listed below, that engages SUMMARY: ATSDR is initiating the
Bank Holding Company either directly or through a subsidiary or development of its 30th set of
other company, in a nonbanking activity toxicological profiles (CERCLA Set 30).
The notificants listed below have that is listed in § 225.28 of Regulation Y This notice announces the list of
applied under the Change in Bank (12 CFR 225.28) or that the Board has proposed substances that will be
Control Act (12 U.S.C. 1817(j)) and determined by Order to be closely evaluated for CERCLA Set 30
§ 225.41 of the Board’s Regulation Y (12 related to banking and permissible for toxicological profile development.
CFR 225.41) to acquire shares of a bank bank holding companies. Unless ATSDR’s Division of Toxicology and
or bank holding company. The factors otherwise noted, these activities will be Human Health Sciences is soliciting
that are considered in acting on the conducted throughout the United States. public nominations from the list of
notices are set forth in paragraph 7 of Each notice is available for inspection proposed substances to be evaluated for
the Act (12 U.S.C. 1817(j)(7)). at the Federal Reserve Bank indicated. toxicological profile development.
The notices are available for The notice also will be available for ATSDR also will consider the
mstockstill on DSK4VPTVN1PROD with NOTICES
immediate inspection at the Federal inspection at the offices of the Board of nomination of any additional, non-
Reserve Bank indicated. The notices Governors. Interested persons may CERCLA substances that may have
also will be available for inspection at express their views in writing on the public health implications, on the basis
the offices of the Board of Governors. question whether the proposal complies of ATSDR’s authority to prepare
Interested persons may express their with the standards of section 4 of the toxicological profiles for substances not
views in writing to the Reserve Bank BHC Act. found at sites on the National Priorities
indicated for that notice or to the offices Unless otherwise noted, comments List. The agency will do so in order to
of the Board of Governors. Comments regarding the notices must be received ‘‘. . . establish and maintain inventory
VerDate Sep<11>2014 17:46 Mar 18, 2016 Jkt 238001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 E:\FR\FM\21MRN1.SGM 21MRN1](https://thefederalregister.org/doc/81_FR_15164/page/1.svg)
![Federal Register / Vol. 81, No. 54 / Monday, March 21, 2016 / Notices 15111
of literature, research, and studies on Substances To Be Evaluated for Set 30 DEPARTMENT OF HEALTH AND
the health effects of toxic substances’’ Toxicological Profiles HUMAN SERVICES
under CERCLA Section 104(i)(1)(B), to
respond to requests for consultation Each year, ATSDR develops a list of Centers for Disease Control and
under section 104(i)(4), and to support substances to be considered for Prevention
the site-specific response actions toxicological profile development. The
[60Day–16–16TZ; Docket No. CDC–2016–
conducted by ATSDR, as otherwise Set 30 nomination process includes 0028]
necessary. consideration of all substances on
ATSDR’s Priority List of Hazardous Proposed Data Collection Submitted
DATES: Nominations from the Substance Substances, also known as the for Public Comment and
Priority List and/or additional Substance Priority List (SPL), as well as Recommendations
substances must be submitted within 30 other substances nominated by the
days of the publication of this notice. AGENCY: Centers for Disease Control and
public. The 275 substances on the SPL,
Prevention (CDC), Department of Health
ADDRESSES: You may submit as well as other substances nominated and Human Services (HHS).
nominations, identified by Docket No. by the public, will be considered for Set
ACTION: Notice with comment period.
ATSDR–2016–0004, by any of the 30 Toxicological Profile development.
following methods: This list may be found at the following SUMMARY: The Centers for Disease
Web site: www.atsdr.cdc.gov/SPL. Control and Prevention (CDC), as part of
*Internet: Access the Federal
Submission of Nominations for the its continuing efforts to reduce public
eRulemaking portal at http://
Evaluation of Set 30 Proposed burden and maximize the utility of
www.regulations.gov. Follow the
Substances: Today’s notice invites government information, invites the
instructions for submitting comments.
voluntary public nominations for general public and other Federal
*Mail: Division of Toxicology and agencies to take this opportunity to
Human Health Sciences, 1600 Clifton substances included on the SPL and for
comment on proposed and/or
Rd. NE., MS F–57, Atlanta, GA 30333 substances not listed on the SPL. All
continuing information collections, as
nominations should include the full
Instructions: All submissions must required by the Paperwork Reduction
name of the nominator, affiliation, and Act of 1995. This notice invites
include the agency name and docket email address. When nominating a non-
number for this notice. All relevant comment on a proposed information
SPL substance, please include the collection project entitled ‘‘Formative
comments will be posted without rationale for the nomination. Please note
change. This means that no confidential Research to Develop HIV Social
that email addresses will not be posted Marketing Campaigns for Healthcare
business information or other
on regulations.gov. Providers.’’ CDC seeks a three-year
confidential information should be
submitted in response to this notice. ATSDR will evaluate all data and approval to collect data from health care
Refer to the section Submission of information associated with nominated providers in order to develop timely,
Nominations (below) for the specific substances and will determine the final relevant, clear, and engaging materials
information required. list of substances to be chosen for that will support patient-provider
toxicological profile development. communications related to HIV
FOR FURTHER INFORMATION CONTACT: For Substances will be chosen according to prevention.
further information, please contact ATSDR’s specific guidelines for DATES: Written comments must be
Commander Jessilynn B. Taylor, selection. These guidelines can be found received on or before May 20, 2016.
Division of Toxicology and Human in the Selection Criteria announced in ADDRESSES: You may submit comments,
Health Sciences, 1600 Clifton Rd. NE.,
the Federal Register on May 7, 1993 identified by Docket No. CDC–2016–
MS F–57, Atlanta, GA 30333, Email:
(58FR27286–27287). A hard copy of the 0028 by any of the following methods:
jxt1@cdc.gov; phone: 770.488.3313. • Federal eRulemaking Portal:
Selection Criteria is available upon
SUPPLEMENTARY INFORMATION: The request or may be accessed at: http:// Regulation.gov. Follow the instructions
Superfund Amendments and www.atsdr.cdc.gov/toxprofiles/ for submitting comments.
Reauthorization Act of 1986 (SARA) [42 guidance/criteria_for_selecting_tp_ • Mail: Leroy A. Richardson,
U.S.C. 9601 et seq.] amended the support.pdf. Information Collection Review Office,
Comprehensive Environmental Centers for Disease Control and
Please ensure that your comments are Prevention, 1600 Clifton Road NE., MS–
Response, Compensation, and Liability submitted within the specified
Act of 1980 (CERCLA or Superfund) [42 D74, Atlanta, Georgia 30329.
nomination period. Nominations Instructions: All submissions received
U.S.C. 9601 et seq.] by establishing received after the closing date will be
certain requirements for ATSDR and the must include the agency name and
marked as late and may be considered Docket Number. All relevant comments
U.S. Environmental Protection Agency
only if time and resources permit. received will be posted without change
(EPA) with regard to hazardous
substances most commonly found at Dated: March 15, 2016. to Regulations.gov, including any
facilities on the CERCLA National personal information provided. For
Pamela Protzel Berman,
Priorities List (NPL). Among these access to the docket to read background
Acting Associate Director, Office of Policy, documents or comments received, go to
statutory requirements is a mandate for Planning and Evaluation, National Center for
Regulations.gov.
the Administrator of ATSDR to prepare
mstockstill on DSK4VPTVN1PROD with NOTICES
Environmental Health/Agency for Toxic
toxicological profiles for each substance Substances and Disease Registry. Please note: All public comment should be
included on the Priority List of [FR Doc. 2016–06277 Filed 3–18–16; 8:45 am]
submitted through the Federal eRulemaking
Hazardous Substances. This list portal (Regulations.gov) or by U.S. mail to the
BILLING CODE 4163–70–P address listed above.
identifies 275 hazardous substances that
ATSDR and EPA have determined pose FOR FURTHER INFORMATION CONTACT: To
the most significant current potential request more information on the
threat to human health. proposed project or to obtain a copy of
VerDate Sep<11>2014 17:46 Mar 18, 2016 Jkt 238001 PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\21MRN1.SGM 21MRN1](https://thefederalregister.org/doc/81_FR_15164/page/2.svg)
Document Created: 2016-03-19 01:00:30
Document Modified: 2016-03-19 01:00:30
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Request for comments on the proposed substances to be evaluated for Set 30 toxicological profiles. | |
| Dates | Nominations from the Substance Priority List and/or additional substances must be submitted within 30 days of the publication of this notice. | |
| Contact | For further information, please contact Commander Jessilynn B. Taylor, Division of Toxicology and Human Health Sciences, 1600 Clifton Rd. NE., MS F-57, Atlanta, GA 30333, Email: [email protected]; phone: 770.488.3313. | |
| FR Citation | 81 FR 15110 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR